Bank of New York Mellon
SLS icon

Bank of New York Mellon’s SELLAS Life Sciences SLS Stock Holding History

Bank of New York Mellon’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82M Buy
530,025
+51,659
+11% +$357K ﹤0.01% 2158
2026
Q1 		$2.02M Buy
478,366
+221,957
+87% +$993K ﹤0.01% 2804
2025
Q4 		$967K Buy
256,409
+50,727
+25% +$98.6K ﹤0.01% 3256
2025
Q3 		$331K Buy
205,682
+4,222
+2% +$7.52K ﹤0.01% 3823
2025
Q2 		$441K Buy
+201,460
New +$309K ﹤0.01% 3575
2024
Q1 		– Sell
-84,665
Closed -$89.7K – 4300
2023
Q4 		$89.7K Buy
84,665
+64,251
+315% +$69.5K ﹤0.01% 4105
2023
Q3 		$33.5K Sell
20,414
-329
-2% -$519 ﹤0.01% 4205
2023
Q2 		$32.6K Sell
20,743
-89
-0.4% -$143 ﹤0.01% 4234
2023
Q1 		$29.8K Hold
20,832
– – ﹤0.01% 4264
2022
Q4 		$49.2K Buy
20,832
+585
+3% +$1.64K ﹤0.01% 4239
2022
Q3 		$41K Hold
20,247
– – ﹤0.01% 4354
2022
Q2 		$45K Sell
20,247
-730
-3% -$2.14K ﹤0.01% 4366
2022
Q1 		$140K Hold
20,977
– – ﹤0.01% 4335
2021
Q4 		$116K Hold
20,977
– – ﹤0.01% 4382
2021
Q3 		$192K Buy
20,977
+645
+3% +$5.98K ﹤0.01% 4226
2021
Q2 		$226K Buy
20,332
+4,728
+30% +$46.1K ﹤0.01% 4057
2021
Q1 		$133K Sell
15,604
-505
-3% -$4.13K ﹤0.01% 4128
2020
Q4 		$94K Hold
16,109
– – ﹤0.01% 4081
2020
Q3 		$43K Hold
16,109
– – ﹤0.01% 4034
2020
Q2 		$47K Hold
16,109
– – ﹤0.01% 3992
2020
Q1 		$28K Buy
+16,109
New +$41.5K ﹤0.01% 4029
2019
Q1 		– Sell
-562
Closed -$35K – 4246
2018
Q4 		$35K Buy
+562
New +$43.5K ﹤0.01% 4104
2017
Q4 		– Sell
-13
Closed -$7K – 4392
2017
Q3 		$7K Buy
13
+4
+44% +$2.64K ﹤0.01% 4251
2017
Q2 		$8K Sell
9
-18
-67% -$15.7K ﹤0.01% 4273
2017
Q1 		$25K Buy
27
+8
+42% +$13.2K ﹤0.01% 4213
2016
Q4 		$55K Buy
+19
New +$110K ﹤0.01% 4120

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Bank of New York Mellon's SLS Position: Q2 2026 in Review

Bank of New York Mellon increased its SELLAS Life Sciences (SLS) stake by 11% in Q2 2026, buying an estimated $357K and bringing the position to 530,025 shares worth $7.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

Bank of New York Mellon first reported a position in SLS in Q4 2016 and has held it in 26 quarters since. 85 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Bank of New York Mellon held 530,025 shares of SELLAS Life Sciences worth $7.82M as of Q2 2026.
  • Bank of New York Mellon bought 51,659 SELLAS Life Sciences shares in Q2 2026, an estimated $357K.
  • SELLAS Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2158 holding.
  • Bank of New York Mellon first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 26 quarters since.
  • 85 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.